K. Nakada et al., IMAGING OF RECURRENT INTESTINAL CARCINOMA WITH INDIUM-111-LABELED ANTICARCINOEMBRYONIC ANTIGEN MONOCLONAL-ANTIBODY CEA102, Japanese journal of cancer research, 88(6), 1997, pp. 605-613
CEA102 is a mouse immunoglobulin G1 monoclonal antibody (mAb) that det
ects an epitope of carcinoembryonic antigen (CEA), The biodistribution
and imaging characteristics of indium-111-labeled (111-In)-mAb CEA102
were studied in 1 primary and 9 extrahepatic recurrent intestinal car
cinoma patients. Evaluation included antibody pharmacokinetics and ass
essment of antibody distribution in surgical specimens, in comparison
with whole body imaging using a gamma camera, and imaging with single
photon emission computed tomography, Selective mAb CEA102 localization
to tumor tissue was demonstrated in 7 patients with tumors over 2 cm
in size, and the external images correlated well with the results of s
urgical inspection, pathological examination, and tissue radioactivity
measurements. Tumor:serum ratios ranged from 0.20:1 to 3.22:1, and se
rial biodistribution study of ''regions of interest'' also demonstrate
d a high radioactivity in the tumor. These results indicated the poten
tial exploitability of the 111-In-labeled mAb CEA102 in radioimmunodet
ection of primary and extrahepatic recurrence of CEA-positive intestin
al carcinomas.